[go: up one dir, main page]

GR1002177B - Method of preparation of injectable clarithromycin - Google Patents

Method of preparation of injectable clarithromycin

Info

Publication number
GR1002177B
GR1002177B GR900100402A GR900100402A GR1002177B GR 1002177 B GR1002177 B GR 1002177B GR 900100402 A GR900100402 A GR 900100402A GR 900100402 A GR900100402 A GR 900100402A GR 1002177 B GR1002177 B GR 1002177B
Authority
GR
Greece
Prior art keywords
preparation
clarithromycin
injectable
injectable clarithromycin
Prior art date
Application number
GR900100402A
Other languages
Greek (el)
Other versions
GR900100402A (en
Inventor
Chiang-Chung Hsu
B John Cannon
Michael W Lovell
Wah-Ho Hui
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of GR900100402A publication Critical patent/GR900100402A/en
Publication of GR1002177B publication Critical patent/GR1002177B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10CWORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00Working-up pitch, asphalt, bitumen
    • C10C3/002Working-up pitch, asphalt, bitumen by thermal means
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10CWORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00Working-up pitch, asphalt, bitumen
    • C10C3/06Working-up pitch, asphalt, bitumen by distillation
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • D01F9/08Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
    • D01F9/12Carbon filaments; Apparatus specially adapted for the manufacture thereof
    • D01F9/14Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
    • D01F9/145Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from pitch or distillation residues
    • D01F9/155Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from pitch or distillation residues from petroleum pitch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Civil Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Textile Engineering (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR900100402A 1989-05-26 1990-05-28 Method of preparation of injectable clarithromycin GR1002177B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35828389A 1989-05-26 1989-05-26

Publications (2)

Publication Number Publication Date
GR900100402A GR900100402A (en) 1991-10-10
GR1002177B true GR1002177B (en) 1996-03-07

Family

ID=23409043

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100402A GR1002177B (en) 1989-05-26 1990-05-28 Method of preparation of injectable clarithromycin

Country Status (9)

Country Link
EP (1) EP0473707A4 (en)
JP (1) JP2963537B2 (en)
KR (1) KR920700655A (en)
AU (1) AU630469B2 (en)
CA (1) CA2056445A1 (en)
GR (1) GR1002177B (en)
IL (1) IL94516A (en)
NZ (1) NZ233827A (en)
WO (1) WO1990014094A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
DE4447972B4 (en) * 1993-05-27 2007-12-27 Novartis Ag Pharmaceutical preparations contg macrolide antibiotics - contain, as the carrier, a mixt of a hydrophilic phase, a lipophilic phase and a surfactant
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
DE4410637C1 (en) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injectable solutions of dirithromycin
CA2189001A1 (en) * 1994-04-26 1995-11-02 Nobuhiro Narita Medicinal composition as a remedy for nonsmall cell lung cancer
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
CN1617709A (en) * 2001-12-13 2005-05-18 兰贝克赛实验室有限公司 Stable topical formulations of clarithromycin
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
RU2423128C2 (en) 2006-03-08 2011-07-10 Нихон Нохияку Ко., Лтд. Pharmaceutical composition for external application
EP2025337B1 (en) 2006-03-08 2014-09-10 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
CN101808638B (en) 2007-09-05 2012-07-25 宝丽制药股份有限公司 Antifungal composition
WO2009031644A1 (en) 2007-09-05 2009-03-12 Pola Pharma Inc. Antifungal pharmaceutical composition
WO2009031642A1 (en) 2007-09-05 2009-03-12 Pola Pharma Inc. Pharmaceutical composition
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102481286B (en) 2009-08-25 2014-02-26 宝丽制药股份有限公司 Antimycotic pharmaceutical composition
RU2707748C2 (en) 2013-11-08 2019-11-29 Активус Фарма Ко., Лтд. Composition of an aqueous suspension comprising nanoparticles of macrolide antibiotics
US20200009116A1 (en) * 2017-04-03 2020-01-09 The Centre For Digestive Diseases Administration of antibiotic compounds for the treatment of streptococcal infections for the treatment of psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61291520A (en) * 1985-06-19 1986-12-22 Daigo Eiyou Kagaku Kk Fat emulsion of erythromycin
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
CA1337397C (en) * 1988-09-29 1995-10-24 Hideo Nakajima Emulsified composition

Also Published As

Publication number Publication date
IL94516A0 (en) 1991-03-10
JP2963537B2 (en) 1999-10-18
EP0473707A4 (en) 1992-12-09
AU5811090A (en) 1990-12-18
IL94516A (en) 1994-12-29
JPH04505762A (en) 1992-10-08
WO1990014094A1 (en) 1990-11-29
NZ233827A (en) 1991-06-25
GR900100402A (en) 1991-10-10
EP0473707A1 (en) 1992-03-11
KR920700655A (en) 1992-08-10
AU630469B2 (en) 1992-10-29
CA2056445A1 (en) 1990-11-27

Similar Documents

Publication Publication Date Title
GR1002177B (en) Method of preparation of injectable clarithromycin
PL286019A1 (en) Method of obtaining heteroazepines
PL286707A1 (en) Method of obteining tetraniture
EP0421644A3 (en) Method for preparation of organoalkoxysilanes
GR900100319A (en) Novel thieno-triazolo-diazepino-derivatives preparation method
GR900100795A (en) Injectable solution and preparation process therefor
EP0435149A3 (en) Method of producing 3-dibutyl-amino-6-methyl-7-anilinofluoran
ZA904311B (en) Method of preparing n-oxo-tetrahydro-beta-carbolines
EP0416577A3 (en) Method of preparing levoglucosenone
GB2236204B (en) Method of extending buffer
CS51189A2 (en) Method of 1-methoxy-2-propanone preparation
CS279089A1 (en) Method of 1-amino-7-naphthol preparation
CS214389A1 (en) Method of lysinesalicylate preparation
CS23489A1 (en) Method of z-alkenes preparation
CS35489A1 (en) Method of normethanephrine preparation
CS841188A1 (en) Method of trisdiethylaminosiliciumchloride preparation
CS599789A1 (en) Method of cobalt-zinc double cyclo-tetraphosphates preparation
CS289889A1 (en) Method of double manganese-cobalt cyclo-tetraphosphates preparation
CS118689A1 (en) Method of technical 2-isopropylamino-4-ethylamino-6-chloro-s-triazine
BG47579A1 (en) Method for preparation of photoluminophors
PL280933A1 (en) Method of obtaining 2-chloroethyl-3-chloropropylsulfide
PL282583A1 (en) Method of obtaining 1-methylethylbenzene
PL282259A1 (en) Method of obtaining l-pyroglutamylo-l-histidyl-l-tryptophyl-l-seril-l-thyrosilgliosyl-l-leukocyl-l-arginyl-l-polyglycinamide
PL281664A1 (en) Method of obtaining chloromethylepoxybutanes
CS8902792A1 (en) 2-acetamido-2-deoxy-beta-d-glucopyranozylmethylamine and method of its preparation

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees